Litcius/Paper detail

Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

Qi Liu, Junqiang Chen, Lin Yu, Jinjun Ye, Wenbin Shen, Honglei Luo, Baosheng Li, Wei Huang, Shihong Wei, Jibin Song, Yaohui Wang, Huanjun Yang, Songtao Lai, Hongcheng Zhu, Dashan Ai, Yun Chen, Jiaying Deng, Shengnan Hao, Kuaile Zhao

2023˜The œLancet. Gastroenterology & hepatology77 citationsDOI

Topics & Concepts

Open labelMedicineIntervention (counseling)Basal cellEsophageal squamous cell carcinomaOncologyInternal medicineRandomized controlled trialCarcinomaPhysical therapyPsychiatryEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial | Litcius